why choose us

Clinical Trials Search

Showing 14,330 of 132,656 result(s)
Health Risks and Barriers to Management Across the PCOS Lifespan

Status: Completed

Condition: Polycystic Ovary Syndrome

Interventions:

Date: 2023-03-03

NEXUS - Next Generation Health Through 2D & 3D Fetal UltraSound; Building Connections to Support Maternal-fetal Health

Status: Completed

Condition: Pregnancy Related

Interventions: During the fetal ultrasound protocol, the NEXUS intervention is added for the component of 'attachment promotion' as it is a natural extensi

Date: 2023-03-03

Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC

Status: Completed

Condition: Hepatocellular Carcinoma

Interventions: Atezolizumab is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer

Date: 2023-03-03

Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients

Status: Completed

Condition: BK Viremia; BKV DNAemia

Interventions: Participants in the study arm will each receive 4 doses (1,000 mg) administered at 4 weekly intervals administered on Days 1, 29, 57 and 85.

Date: 2023-03-03

Cognitive Behavioral Therapy for Adolescents With Bulimia Nervosa and Higher Weight (Online Treatment Study)

Status: Completed

Condition: Bulimia Nervosa

Interventions: Cognitive Behavioral Therapy (CBT) is a psychological treatment or "talk therapy" that integrates how people think, feel, and behave to crea

Date: 2023-03-03

Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population

Status: Completed

Condition: Overweight

Interventions: Meal replacement products offered through the Massachusetts General Hospital Weight Center.

Date: 2023-03-03

Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma

Status: Completed

Condition: Glioblastoma

Interventions: Given PO

Date: 2023-03-03

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

Status: Completed

Condition: Renal Cell Carcinoma

Interventions: RO7515629 will be administered intravenously at a dose and schedule as specified for the respective study part and cohort.

Date: 2023-03-03

Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta

Status: Completed

Condition: Osteogenesis Imperfecta

Interventions: Administered per investigator discretion via intravenous (IV) infusion

Date: 2023-03-03

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

Status: Completed

Condition: Metastatic HER2-Negative Breast Carcinoma

Interventions: Undergo blood sample collection for banking

Date: 2023-03-03